Emmanuel Coeytaux
Geen lopende functies
Vermogen: 633 680 $ op 30-04-2024
Profiel
Dr. Emmanuel Coeytaux was previously employed as an EVP, Strategy & COO by DRI Capital, Inc. and a President by Steba Biotech NV.
He received his graduate degree from Ecole Polytechnique.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DRI HEALTHCARE TRUST
0.07% | 25-10-2023 | 41 417 ( 0.07% ) | 633 680 $ | 30-04-2024 |
Eerdere bekende functies van Emmanuel Coeytaux
| Bedrijven | Functie | Einde |
|---|---|---|
Steba Biotech NV
 Steba Biotech NV Pharmaceuticals: MajorHealth Technology Steba Biotech NV is a Dutch company that manufactures cancer drugs. The CEO of the private company is Yehoshua Shemer. | President | 01-02-2021 |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Operationeel Directeur | - |
Opleiding van Emmanuel Coeytaux
| Ecole Polytechnique | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
DRI Capital, Inc.
DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
Steba Biotech NV
Steba Biotech NV Pharmaceuticals: MajorHealth Technology Steba Biotech NV is a Dutch company that manufactures cancer drugs. The CEO of the private company is Yehoshua Shemer. | Health Technology |
